Why Urinary Albumin Decreases While Albumin-Creatinine Ratio Remains Unchanged
When urinary albumin concentration falls but the albumin-creatinine ratio (ACR) stays constant, urinary creatinine excretion has decreased proportionally—most commonly due to declining muscle mass, reduced dietary protein intake, or changes in hydration status that affect both analytes equally. 1
Physiologic Explanation
The albumin-creatinine ratio is calculated by dividing urinary albumin (mg) by urinary creatinine (g), then multiplying by 1000 to express the result in mg/g. When both the numerator (albumin) and denominator (creatinine) decrease by the same percentage, the ratio remains mathematically unchanged. 1
Primary Mechanisms
Reduced muscle mass is the most common cause of declining urinary creatinine excretion, because creatinine is a metabolic byproduct of muscle creatine phosphate breakdown. 2, 3
Lower dietary protein intake decreases both albumin filtration (through reduced glomerular hyperfiltration) and creatinine production, maintaining a stable ratio. 1
Improved hydration status can dilute both albumin and creatinine proportionally in spot urine samples, though first-morning void collections minimize this effect. 1
Aging progressively reduces muscle mass and creatinine excretion; older individuals have 4% higher ACR per 5-year age increment independent of actual albumin excretion. 3
Female sex is associated with 26% higher ACR than males at equivalent timed albumin excretion rates, because women have lower muscle mass and creatinine production. 3, 4
Clinical Implications
When ACR Remains Stable Despite Falling Albumin
This pattern does not indicate worsening kidney disease if the ACR stays below 30 mg/g, because both components are declining together. 1, 5
Confirm the finding with repeat first-morning void specimens collected 3–6 months apart, because within-individual ACR variability can reach 48.8% even in stable patients. 6
Measure serum creatinine and calculate eGFR annually, because 20–40% of diabetic patients develop reduced eGFR without albuminuria, and declining urinary creatinine may signal sarcopenia that masks true kidney function. 5
Avoiding Misinterpretation
Do not assume stable ACR means stable kidney function when urinary creatinine is falling, because low muscle mass can artificially elevate ACR and create false-positive microalbuminuria diagnoses. 2
In the Gubbio Population Study, 5.2% of participants had elevated ACR (≥17 µg/mg in men, ≥25 µg/mg in women) without true microalbuminuria (albumin 20–199 µg/min); these individuals had low muscle mass, low urinary creatinine, and no increased cardiovascular risk (8.2% vs. 7.1% coronary disease prevalence, P=0.706). 2
High ACR driven by low creatinine rather than high albumin does not predict cardiovascular events, whereas true albuminuria increases mortality risk 2–4-fold. 5, 2
Adjusting for Muscle Mass Differences
Gender- and race-specific creatinine correction factors (k = 0.68 for White men, 0.88 for Black men and Black women, 1.0 for White women) can improve ACR accuracy by accounting for physiologic differences in creatinine excretion. 4
Without adjustment, unadjusted ACR underestimates microalbuminuria prevalence by 52% in men and 26% in Black individuals compared to timed albumin excretion. 4
The PREVEND study confirmed that low spot urine creatinine concentration (expressed as 1/creatinine) independently predicts cardiovascular events (HR 1.16 per ln-SD), but high urine albumin is a stronger determinant of the ACR–cardiovascular disease association (HR 1.26 per ln-SD for albumin vs. 1.41 for ACR). 3
Monitoring Strategy
Frequency and Method
Continue annual ACR and eGFR testing for all patients with diabetes (type 2 from diagnosis; type 1 after 5 years' duration) or other CKD risk factors. 5
Use first-morning void specimens to minimize diurnal variation (coefficient of variation 31% vs. 36% for random samples) and orthostatic proteinuria. 1, 5
Avoid vigorous exercise for 24 hours before collection and ensure the patient is free of urinary tract infection, fever, marked hyperglycemia, or marked hypertension, all of which transiently raise albumin excretion. 1, 5
Interpreting Trends
A stable ACR <30 mg/g requires no pharmacologic intervention regardless of absolute albumin or creatinine values, provided eGFR remains ≥60 mL/min/1.73 m². 5
If ACR crosses 30 mg/g on repeat testing, confirm persistent elevation with ≥2 of 3 positive results over 3–6 months before initiating ACE-inhibitor or ARB therapy. 5
Monitor for sarcopenia when urinary creatinine declines, because low muscle mass independently predicts cardiovascular mortality and may warrant nutritional or physical therapy interventions. 2, 3
Key Pitfalls
Never diagnose worsening kidney disease based on stable ACR alone; always correlate with eGFR trends and clinical context. 5
Never measure albumin concentration without creatinine correction, because hydration variability makes isolated albumin values unreliable. 1, 7
Never assume a normal ACR excludes kidney disease; reduced eGFR can occur without albuminuria in 20–40% of diabetic CKD patients. 5
Never start ACE-inhibitor or ARB therapy when ACR is <30 mg/g and blood pressure is normal, as this provides no renal benefit and may cause hyperkalemia or acute kidney injury. 5